NCT02422953 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Donner, A
and Klar, N. Design and Analysis of Cluster Randomization Trials in Health Research. Arnold, London; 2000
Gorstein J, Sullivan KM, Parvanta I, Begin F
Indicators and Methods for Cross-Sectional Surveys of Vitamin and Mineral Status of Populations. The Micronutrient Initiative (Ottawa) and the Centers for Disease Control and Prevention (Atlanta), May 2007.
Horton, S
Opportunities for investments in nutrition in low-income Asia; 1999. Asian Development Review 17 (1, 2): 246-273.
National Nutrition Survey (NNS), 2011
Planning Commission Planning and Development Division Government of Pakistan.
WFP (2012): Protracted Relief and Recovery Operations (PRRO)
Pakistan 200250. Rome, Italy.

Effectiveness of Food/Nutrient Based Interventions to Prevent Stunting Among Children Under Five in Thatta and Sujawal Districts, Sindh Province, Pakistan

Details for clinical trial NCT02422953

Clinical trial NCT02422953 - References